Literature DB >> 23140620

[Diagnosis of pelvic inflammatory disease. Which clinical and paraclinical criteria? Role of imaging and laparoscopy?].

J Bouquier1, A Fauconnier, W Fraser, A Dumont, C Huchon.   

Abstract

Diagnosis of pelvic inflammatory disease is difficult. We focus on a systematic literature review to study diagnostic values of history-taking, clinical examination, laboratory tests and imagery. After this literature review, we build a diagnostic model for pelvic inflammatory disease. This diagnostic model is built on two major criteria: presence of adnexal tenderness or cervical motion tenderness. Additional minor criteria, increasing the likelihood of the diagnosis of pelvic inflammatory disease were added based on their specificity and their positive likelihood ratio. These minor criteria are supported by history-taking, clinical examination, laboratory tests and also on relevant ultrasonographic criteria.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23140620     DOI: 10.1016/j.jgyn.2012.09.016

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

1.  Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.

Authors:  Jeanne Tamarelle; Anne C M Thiébaut; Bénédicte Sabin; Cécile Bébéar; Philippe Judlin; Arnaud Fauconnier; Delphine Rahib; Layidé Méaude-Roufai; Jacques Ravel; Servaas A Morré; Bertille de Barbeyrac; Elisabeth Delarocque-Astagneau
Journal:  Trials       Date:  2017-11-13       Impact factor: 2.279

2.  Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial.

Authors:  Cyrille Huchon; Martin Koskas; Aubert Agostini; Cherif Akladios; Souhail Alouini; Estelle Bauville; Nicolas Bourdel; Hervé Fernandez; Xavier Fritel; Olivier Graesslin; Guillaume Legendre; Jean-Philippe Lucot; Isabelle Matheron; Pierre Panel; Cyril Raiffort; Arnaud Fauconnier
Journal:  Trials       Date:  2015-08-19       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.